Fundz

Who to call at Metabolon, and when

Fundz watches for the moments Metabolon starts buying, and tells you who to reach.

  • An alert the day Metabolon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Metabolon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Metabolon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Identify Rheumatoid Arthritis Biomarkers

Aug 28, 2024

Contract Type

partnership

DurhamBiotechnologyHealthcare

Description

Metabolon, Inc. and the Scottish Early Rheumatoid Arthritis (SERA) Study have announced a partnership to identify circulating small molecules as biomarkers of rheumatoid arthritis, aiming to improve the understanding of disease risk, progression, and treatment response. The partnership will combine metabolomic data with clinical and genomic information to reveal the molecular mechanisms of rheumatoid arthritis development and progression.

Company Information

Company

Metabolon

Location

617 Davis Drive, Suite 100

Durham, North Carolina, United States

About

Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other 'omics' technologies. With 25 years of experience, 15,000+ client projects, 4,000+ scientific publication references, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques. Metabolon's Global Discovery Panel is powered by the world's largest proprietary metabolomics reference library. Metabolon's industry-leading data and translational science expertise help customers and partners address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success. The company offers scalable, customizable multiomics solutions, including metabolomics and lipidomics, that support customer needs from discovery through clinical trials and product life-cycle management.

Related People

Karl
Senior decision-maker at this company
••••••••@••••••••

See Karl's verified email →

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Celia
Likely contact at this company
••••••••@••••••••

See Celia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Metabolon's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Metabolon signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.